Document:

EX-10.14

 Exhibit 10.14 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [****], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE REGISTRANT
TREATS AS PRIVATE OR CONFIDENTIAL. 
  

					
	S13-348MW	  	AMENDMENT	  	7/5/2016

 AMENDMENT No. 1 

TO THE 
 LICENSE
AGREEMENT EFFECTIVE THE 23RD DAY OF MARCH 2016 
 BETWEEN 

STANFORD UNIVERSITY 

AND 
 SURROZEN 

Effective the 5th day of July 2016, THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (“Stanford”), an institution of higher education
having powers under the laws of the State of California, and Surrozen (“Surrozen”), a corporation having a principal place of business at 1700 Owens St., Suite 500, San Francisco, CA 94158 agree as follows: 

 

	1.	 BACKGROUND 

Stanford and Surrozen are parties to a license agreement effective the 23rd day of March 2016 (“Original Agreement”) covering “Surrogate WNT
Proteins” disclosed in Stanford docket [****]. 
 Stanford and Surrozen wish to amend the Original Agreement to add additional past patent expenses.

  

	2.	 AMENDMENT 

Paragraph 14.2(A) of Original Agreement is hereby replaced by the following: 
  

	 	(A)	 [****] to offset Licensed Patent’s patenting expenses, including any interference or reexamination
matters, incurred by Stanford before the Effective Date. Surrozen is responsible for paying [****] of these past patenting expenses upon the Effective Date with the remaining amount of [****] due [****] of the Effective Date or [****], whichever
date occurs first; and 

  

	3.	 OTHER TERMS 

  

	3.1	 All other terms of the Original Agreement remain in full force and effect. 

 

	3.2	 The parties to this document agree that a copy of the original signature (including an electronic copy) may be
used for any and all purposes for which the original signature may have been used. 

  
  

PAGE 1 OF 2 

					
	S13-348:MW	  	AMENDMENT	  	7/5/2016

  

 The parties further waive any right to challenge the admissibility or authenticity of this
document in a court of law based solely on the absence of an original signature. 
 IN WITNESS WHEREOF, the parties hereto have executed this Amendment No 1
in duplicate originals by their duly authorized officers or representatives. 
  

			
	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
		
	Signature:	 	 /s/ Luis R. Mejia

	Name:	 	 Luis R. Mejia

	Title:	 	 Associate Director, OTL

		
	Date:	 	 July 14, 2016

	
	SURROZEN
		
	Signature:	 	 /s/ Tim Kutzkey

	Name:	 	 Tim Kutzkey

	Title:	 	 President and CEO

		
	Date:	 	 July 14, 2016

  
  

PAGE 2 OF 2EX-10.15

 Exhibit 10.15 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [****], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE REGISTRANT
TREATS AS PRIVATE OR CONFIDENTIAL. 
  

					
	S13-348:MW	  	AMENDMENT	  	10/7/2016

 AMENDMENT NO 2 

TO THE 
 LICENSE
AGREEMENT EFFECTIVE THE 23RD DAY OF MARCH 2016 
 BETWEEN 

STANFORD UNIVERSITY 

AND 
 SURROZEN 

Effective the 7th day of October 2016, THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (“Stanford”), an institution of higher
education having powers under the laws of the State of California, and Surrozen (“Surrozen”), a corporation having a principal place of business at 240 E. Grand Ave., 2nd Floor, South San Francisco, CA 94080 agree as follows: 

 

	1.	 BACKGROUND 

Stanford and Surrozen are parties to a license agreement effective the 23rd day of March 2016 (“Original Agreement”) covering “Surrogate WNT
Proteins” disclosed in Stanford docket [****]. 
 Stanford and Surrozen wish to further amend the Original Agreement to add a new provisional patent
application to the license. 
  

	2.	 AMENDMENT 

Paragraph 2.6 of Original Agreement is hereby deleted in its entirety and replaced with the following: 

2.6    “Licensed Patent” means U.S. Patent Applications, [****], any foreign patent application corresponding thereto, and any
divisional, continuation, or reexamination application, extension, and each patent that issues or reissues from any of these patent applications. Any claim of an unexpired Licensed Patent is presumed to be valid unless it has been held to be invalid
by a final judgment of a court of competent jurisdiction from which no appeal can be or is taken. “Licensed Patent” excludes any continuation-in-part (CIP)
patent application or patent. Neither party shall file or authorize another party to file a CIP of any Licensed Patent without the written approval of the other Party. 

  
  

PAGE 1 OF 2 

					
	S13-348:MW	  	AMENDMENT	  	10/7/2016

  

	3.	 OTHER TERMS 

  

	3.1	 Within [****] following execution of this Amendment, Surrozen will pay Stanford [****] to cover past patent
costs for the added patent application. All other terms of the Original Agreement remain in full force and effect. 

  

	3.2	 The parties to this document agree that a copy of the original signature (including an electronic copy) may be
used for any and all purposes for which the original signature may have been used. The parties further waive any right to challenge the admissibility or authenticity of this document in a court of law based solely on the absence of an original
signature. 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment No 2 in duplicate originals by their duly authorized
officers or representatives. 
  

			
	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
		
	Signature:	 	 /s/ Katharine Ku

	Name:	 	      

	Title:	 	 Executor Director

Technology Licensing

		
	Date:	 	 Oct 25, 2016

	
	SURROZEN
		
	Signature:	 	 /s/ Tim Kutzkey

	Name:	 	Tim Kutzkey
	Title:	 	CEO
		
	Date:	 	10/24/16

  
  

PAGE 2 OF 2EX-10.16

 Exhibit 10.16 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [****], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE REGISTRANT
TREATS AS PRIVATE OR CONFIDENTIAL. 
 AMENDMENT NO. 3 TO 

EXCLUSIVE (EQUITY) AGREEMENT 

THIS AMENDMENT NO. 3 TO THE EXCLUSIVE (EQUITY) AGREEMENT (this “Amendment”) dated as of January 19, 2021 (the “Amendment
Date”), is entered into between Surrozen, Inc., a Delaware corporation (hereinafter, “Surrozen”), having offices at 171 Oyster Point Blvd., Suite 400, South San Francisco, CA 94080 and Board of Trustees of the Leland Stanford Junior
University (hereinafter, “Stanford”), an institution of higher education, having powers under the laws of the State of California, and having offices at 3000 El Camino Real, Building 5, Suite 300, Palo Alto, CA 94306-2100, with respect to
the following facts: 
 A.    The Parties entered into the EXCLUSIVE (EQUITY) AGREEMENT on March 23, 2016, and
subsequently amended on July 5, 2016 (Amendment No. 1) and again on October 7, 2016 (Amendment No. 2; collectively the “Agreement”). All terms used, but not defined, herein shall have the respective meanings set forth
in the Agreement. 
 B.    The Parties now desire to amend the Agreement in certain respects on the terms and conditions
set forth below. 
 NOW THEREFORE, in consideration of the foregoing premises and the mutual covenants set forth below, the Parties hereby
amend the Agreement and otherwise agree as follows: 
  

	 	1.	 Amendments. 

  

	 	1.1	 The Preamble is amended as follows: 

 

	 	•	 	 This Agreement between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (“Stanford”), an
institution of higher education having powers under the laws of the State of California, and Surrozen, Inc. (“Surrozen”), a Delaware corporation having a principal place of business at 171 Oyster Point Blvd., Suite 400, South San
Francisco, CA 94080, is effective on the 23rd day of March, 2016 (“Effective Date”). 

  

	 	1.2	 Section 2.5 is amended as follows: 

 

	 	•	 	 “Licensed Field of Use” means treatment, palliation, diagnosis, assessment or prevention of any human
or veterinary disease, disorder or condition. 

  

	 	1.3	 Section 7.7 is amended as follows: 

 

	 	•	 	 Milestone Payments. Surrozen will pay Stanford the following milestone payments: 

[****] 
 [****] 

 [****] 

[****] 
 [****] 

[****] 
 [****] 

[****] 
 [****] 

 

	 	1.4	 Section 7.8 is amended as follows: 

 

	 	•	 	 Earned Royalty. Surrozen will pay Stanford earned royalties of [****] on Net Sales booked by Surrozen of a
Licensed Product that is covered by a Valid Claim. Surrozen will pay Stanford earned royalties of [****] on Net Sales booked by a sub-licensee of a Licensed Product that is covered by a Valid Claim.

  

	 	1.5	 Section 18.2 is amended as follows: 

 

	 	•	 	 All Notices. All notices under this Agreement are deemed fully given when written, addressed and sent as
follows: 

 All general notices to Surrozen are mailed or emailed to: 

[****] 
 [****] 

[****] 
 [****] 

[****] 
 [****] 

All financial invoices to Surrozen (i.e., accounting contact) are emailed to: 

[****] 
 [****] 

All progress reports to Surrozen (i.e., technical contact) are emailed to: 

[****] 
 [****] 

  
 2 

 [****]Appendix A is amended as follows:[****] 

[****] 
 [****] 

[****] 
 [****] 

[****] 
 [****] 

 

	 	2.	 Miscellaneous. 

2.1    This Amendment shall be effective for all purposes as of January 19, 2021. Except as otherwise expressly
modified by this Amendment, the Agreement shall remain in full force and effect in accordance with its terms. 

2.2    Upon execution of this Amendment, Surrozen will pay to Stanford a [****] amendment fee. 

2.3    This Amendment may be executed in counterparts, each of which shall be deemed to be an original and together shall
be deemed to be one and the same agreement. 
 2.4    This Agreement has been executed in the State of California and
its validity, construction, and all rights under it shall be governed by the laws of the State of California without reference to conflicts of law principles. 

IN WITNESS WHEREOF, the Parties have duly executed and delivered this Amendment as of the Amendment Date. 

 

									
	SURROZEN, INC.	 		 	BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
					
	By:	 	 /s/ Craig Parker
	 		 	By:	 	 /s/ Sunita Rajdev

		 	 Craig Parker
	 		 		 	 Sunita Rajdev

		 	 CEO
	 		 		 	 Senior Associate Director

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]